Avid Bioservices's Enterprise Value for the quarter that ended in Oct. 2023 was $552.8 Mil.
Avid Bioservices's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was $-8.6 Mil. Avid Bioservices's Earnings Yield (Joel Greenblatt) for the quarter that ended in Oct. 2023 was -1.56%.
The historical rank and industry rank for Avid Bioservices's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
CDMO'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -431.9 Med: -1.87 Max: 76.52
Current: -1.39
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Avid Bioservices was 76.52%. The lowest was -431.90%. And the median was -1.87%.
CDMO's Earnings Yield (Joel Greenblatt) % is ranked better than 76.93% of 1400
companies
in the Biotechnology industry
Industry Median: -15.14
vs CDMO: -1.39
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Avid Bioservices's Forward Rate of Return (Yacktman) % for the quarter that ended in Oct. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Avid Bioservices Earnings Yield (Joel Greenblatt) % Historical Data
The historical data trend for Avid Bioservices's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Avid Bioservices Annual Data
Trend
Apr14
Apr15
Apr16
Apr17
Apr18
Apr19
Apr20
Apr21
Apr22
Apr23
Earnings Yield (Joel Greenblatt) %
-2.25
-3.12
0.99
1.73
0.36
Avid Bioservices Quarterly Data
Jan19
Apr19
Jul19
Oct19
Jan20
Apr20
Jul20
Oct20
Jan21
Apr21
Jul21
Oct21
Jan22
Apr22
Jul22
Oct22
Jan23
Apr23
Jul23
Oct23
Earnings Yield (Joel Greenblatt) %
0.38
0.41
0.36
-0.01
-1.56
Competitive Comparison
For the Biotechnology subindustry, Avid Bioservices's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avid Bioservices Earnings Yield (Joel Greenblatt) % Distribution
For the Biotechnology industry and Healthcare sector, Avid Bioservices's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Avid Bioservices's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Avid Bioservicess Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Apr. 2023 is calculated as
Avid Bioservices's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.6 Mil.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Avid Bioservices Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of Avid Bioservices's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
Avid Bioservices (Avid Bioservices) Business Description
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CDMO has been successfully added to your 